
| Code | Targets | Indications | Preclinical | IND | Ph I | Ph II | Ph III | NDA/BLA |
|---|---|---|---|---|---|---|---|---|
| UB367 | IL-17A/F | Psoriasis | ||||||
| UB365 | TRKA (Gel) | Skin inflammation; Pruritus | ||||||
| UB362 | JAK1 (oral) | Vitiligo | ||||||
| UB361 | JAK1 (oral) | Atopic dermatitis | ||||||
| UB341 | TL1A; IL-23p19 | Inflammatory bowel disease; Psoriasis | ||||||
| UB148 | Androgen receptor | Acne | ||||||
| UB147 | Keratin; Plasmin | Chloasma | ||||||
| UB067 | JAK1 (Gel) | Atopic dermatitis | ||||||
获取最新活动与法规动态洞察
直接发送到您的邮箱
在此获取行业洞察与 Unibest 动态
联系我们 →